1. Home
  2. INVE vs LXEO Comparison

INVE vs LXEO Comparison

Compare INVE & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • LXEO
  • Stock Information
  • Founded
  • INVE 1990
  • LXEO 2017
  • Country
  • INVE United States
  • LXEO United States
  • Employees
  • INVE N/A
  • LXEO N/A
  • Industry
  • INVE Computer peripheral equipment
  • LXEO
  • Sector
  • INVE Technology
  • LXEO
  • Exchange
  • INVE Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • INVE 82.2M
  • LXEO 93.9M
  • IPO Year
  • INVE 1997
  • LXEO 2023
  • Fundamental
  • Price
  • INVE $3.27
  • LXEO $2.72
  • Analyst Decision
  • INVE Strong Buy
  • LXEO Strong Buy
  • Analyst Count
  • INVE 3
  • LXEO 6
  • Target Price
  • INVE $6.50
  • LXEO $18.50
  • AVG Volume (30 Days)
  • INVE 57.4K
  • LXEO 984.8K
  • Earning Date
  • INVE 05-07-2025
  • LXEO 05-12-2025
  • Dividend Yield
  • INVE N/A
  • LXEO N/A
  • EPS Growth
  • INVE N/A
  • LXEO N/A
  • EPS
  • INVE 3.12
  • LXEO N/A
  • Revenue
  • INVE $25,239,000.00
  • LXEO N/A
  • Revenue This Year
  • INVE N/A
  • LXEO N/A
  • Revenue Next Year
  • INVE $8.95
  • LXEO N/A
  • P/E Ratio
  • INVE $1.05
  • LXEO N/A
  • Revenue Growth
  • INVE N/A
  • LXEO N/A
  • 52 Week Low
  • INVE $2.86
  • LXEO $1.45
  • 52 Week High
  • INVE $4.51
  • LXEO $19.50
  • Technical
  • Relative Strength Index (RSI)
  • INVE 50.19
  • LXEO 44.00
  • Support Level
  • INVE $3.21
  • LXEO $2.51
  • Resistance Level
  • INVE $3.43
  • LXEO $2.91
  • Average True Range (ATR)
  • INVE 0.13
  • LXEO 0.42
  • MACD
  • INVE 0.00
  • LXEO -0.04
  • Stochastic Oscillator
  • INVE 53.06
  • LXEO 25.00

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: